Skip to main content
Clinical Trials/NCT03191968
NCT03191968
Completed
Phase 2

A Pilot, Randomized Controlled Trial Adding Behavioral Counseling to Supervised Physical Activity in Prostate Cancer Survivors

University of Illinois at Urbana-Champaign1 site in 1 country27 target enrollmentJuly 6, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Physical Activity
Sponsor
University of Illinois at Urbana-Champaign
Enrollment
27
Locations
1
Primary Endpoint
Objectively assessed physical activity
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study will evaluate the feasibility of delivering a supervised physical activity program plus standard exercise counseling (SPA+EC) versus a supervised physical activity plus motivationally-enhanced behavioral counseling (SPA+BC) in prostate cancer survivors (PCS). Fifty participants (n=25) will be randomized to receiving SPA+EC or SPA+BC (n=25). We hypothesize that PCS receiving the SPA+BC intervention will result in greater increases in objectively-assessed physical activity compared with PCS receiving the SPA+EC intervention.

Detailed Description

Physical activity (PA) has a positive impact on clinical outcomes such as improvement in overall QoL, cancer-specific mortality, reducing treatment-related toxicities, and reducing fatigue across many cancer survivor groups including PCS. Despite these benefits of regular PA, the majority of PCS are still not meeting public health PA guidelines. Short-term supervised PA programs have been shown to improve health-related fitness and patient-reported outcomes in PCS, but PA declines significantly after the supervised intervention has been completed. Research examining the effect of short- term supervised exercise programs on motivational outcomes and longer term PA among cancer survivors is limited, especially theoretical approaches to identify key motivational outcomes for behavior change. This study will pilot a two-armed, single blind, RCT comparing SPA+EC to SPA+BC. The proposed RCT in PCS is noteworthy given that it differs from standard approaches to supervised PA with the addition of a behavioral counseling component. This rigorous comparison condition will provide further evidence that theoretically-informed interventions are needed to adopt long-term PA maintenance. The program's supervised exercise length will be 6 weeks, followed by a tapered contact throughout the a 6-week home-based component through 'booster' behavioral counseling delivered via telephone. In terms of study measures, objective measures of PA will be used (i.e.,accelerometry, inclinometers), and cardiorespiratory fitness will be evaluated using maximal graded exercise testing via treadmill. Additional secondary outcomes include cognitive function, quality of life, physical function, body composition, motivational outcomes, sexual functioning, masculinity, sedentary behavior, and cardiorespiratory fitness.

Registry
clinicaltrials.gov
Start Date
July 6, 2017
End Date
May 30, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥18 years and older
  • Histologically confirmed prostate cancer (Stage I-IIIa) but now cured or in remission
  • Ability and willingness to effectively communicate in English
  • Not meeting physical activity guidelines of ≥150 minutes of vigorous physical activity

Exclusion Criteria

  • Severe coronary artery disease (Canadian Cardiovascular Society class III or greater)
  • Significant congestive heart failure (New York Heart Association class III or greater)
  • Uncontrolled pain
  • Neurological or musculoskeletal co-morbidity inhibiting exercise
  • Diagnosed psychotic, addictive or major cognitive disorders
  • Absent for more than 3 consecutive days during the 12-week intervention
  • High risk individuals (i.e., men who have symptomatic and known cardiovascular, pulmonary and/or metabolic disease) as determined by the risk stratification questionnaire

Outcomes

Primary Outcomes

Objectively assessed physical activity

Time Frame: Change in from baseline at 12 weeks

Objective Physical activity will be measured using an activity device, accelerometry (i.e., Actigraph GTX3+)

Secondary Outcomes

  • Physical Function(Change in from baseline at 12 weeks)
  • General well-being(Change in from baseline at 12 weeks)
  • Masculine self-esteem(Change in from baseline at 12 weeks)
  • Self-reported physical activity(Change in from baseline at 12 weeks)
  • General quality of life(Change in from baseline at 12 weeks)
  • Prostate-specific quality of life(Change in from baseline at 12 weeks)
  • Cancer-related fatigue(Change in from baseline at 12 weeks)
  • Body composition(Change in from baseline at 12 weeks)
  • Cognitive function(Change in from baseline at 12 weeks)
  • Cardiorespiratory fitness(Change in from baseline at 12 weeks)
  • Relationship quality(Change in from baseline at 12 weeks)
  • Sexual Health(Change in from baseline at 12 weeks)
  • Motivational outcomes(Change in from baseline at 12 weeks)
  • Self-reported sedentary behavior(Change in from baseline at 12 weeks)
  • Objectively assessed sedentary behavior(Change in from baseline at 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials